Eurasian Journal of Medicine, published by Atatürk University, stands as a vital resource in the field of medicine, particularly within the context of Eurasian healthcare advancements. Established as an Open Access journal since 1969, it is committed to distributing high-quality research widely, ensuring that vital findings are accessible to researchers, practitioners, and medical students alike. With an impact factor indicative of its relevance, the journal is currently ranked #251 out of 636 in the "General Medicine" category within Scopus, placing it in the 60th percentile and holding a Q3 quartile classification for 2023. Covering a diverse range of topics in medicine from 2012 to 2024, the journal publishes novel research, reviews, and clinical studies that contribute to the understanding and practice of medicine in transition. Located in Erzurum, Turkey, the Eurasian Journal of Medicine aspires to foster dialogue and innovation in the medical community worldwide.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that covers pivotal research in the fields of neurology, neurosurgery, and psychiatry. With an impressive impact factor and consistently recognized as a Q1 journal in its respective categories—including Clinical Neurology, Psychiatry and Mental Health, and Surgery—this publication ranks in the top percentiles on Scopus, showcasing its influence in the medical community. Since its inception in 1920, the journal has been committed to delivering high-quality, peer-reviewed content to researchers, clinicians, and students alike, maintaining an exceptional reputation attributed to its rigorous selection process and the depth of its contributions. Access to the journal's articles fosters a comprehensive understanding of progressive research and clinical practices, solidifying its significance for professionals aiming to navigate the complexities of neurological and psychiatric disorders. As a vital resource based in the United Kingdom, the journal continues to propel innovation and knowledge sharing in the ever-evolving landscape of neurohealth.

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.

Journal of Psychopathology, published by PACINI EDITORE, is a pivotal academic resource in the realms of clinical psychology and psychiatry. With an ISSN of 1592-1107 for print and 2499-6904 for electronic formats, this journal has been a significant platform for scholarly discourse since its inception in 2001, continuing through to 2024. Situated in Pisa, Italy, it is recognized for its rigorous academic standards, as evidenced by its Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health categories as of 2023. The journal focuses on publishing high-quality research articles, reviews, and case studies that contribute to a comprehensive understanding of psychopathological issues. Although not open access, the journal promotes accessibility through various institutional subscriptions, ensuring wide dissemination of valuable insights. With significant Scopus rankings—177 out of 311 in Clinical Psychology and 360 out of 567 in Psychiatry and Mental Health—the journal is essential for researchers, practitioners, and students dedicated to advancing knowledge and practices in mental health.

REVISTA DE NEUROLOGIA is a distinguished academic journal focusing on the broad fields of neurology and medicine, published in Spain since its inception in 1959. The journal plays a vital role in disseminating significant research findings, clinical studies, and advancements in neurological science, catering to an audience of researchers, clinicians, and students alike. With an ISSN of 0210-0010 and an E-ISSN of 1576-6578, this quarterly publication has maintained its commitment to enhancing the understanding of neurological disorders and therapies through rigorous peer-reviewed articles. While currently not classified as open access, it is indexed in Scopus, holding a rank of #253 out of 400 in the category of Medicine (Neurology), reflecting its relevance in the field with a 36th percentile. The journal is positioned within the Q3 quartile for both Medicine (miscellaneous) and Clinical Neurology categories as of 2023. Based in Barcelona, Spain, it is a vital resource for anyone devoted to the advancement of knowledge and practice in neurology.

NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.

GENERAL HOSPITAL PSYCHIATRY is a leading academic journal dedicated to the interdisciplinary fields of psychiatry and mental health, published by Elsevier Science Inc. With a substantial impact factor, this journal is recognized as a Q1 publication in its field, reflecting its significant contribution to advancing research and practice. Since its inception in 1979, GENERAL HOSPITAL PSYCHIATRY has provided a crucial platform for innovative studies, clinical findings, and discussions surrounding mental health care within a hospital setting. The journal addresses a wide range of topics, including psychiatric assessment, diagnosis, treatment interventions, and public health strategies, positioning itself at the forefront of psychiatric research. Though currently not open access, it strives to disseminate knowledge that is vital for healthcare professionals, researchers, and students aiming to enhance mental health outcomes. With an impressive convergence timeline extending to 2024, this journal is essential for anyone invested in the scholarly exploration of psychiatry.

Dusunen Adam-Journal of Psychiatry and Neurological Sciences is a vital resource for scholars and practitioners in the fields of psychiatry and neurology, published by KARE PUBL in Turkey. With an ISSN of 1018-8681 and E-ISSN 1309-5749, this journal has steadily contributed to the academic discourse since its inception, with a dedicated focus on contemporary issues and research findings in psychological and neurological sciences. The journal, which is recognized as Q3 in both the Neurology (clinical) and Psychiatry and Mental Health categories, currently ranks #413 out of 567 in Psychiatry and Mental Health and #298 out of 400 in clinical Neurology according to Scopus. Its commitment to advancing knowledge in these critical areas makes it a significant platform for researchers, professionals, and students alike, fostering a deeper understanding of mental health and neurological disorders that are increasingly relevant in our society. As Dusunen Adam continues to evolve through its convergence years from 2011 to 2024, it remains dedicated to enhancing the quality of life through research and evidence-based practices.

Multiple Sclerosis and Related Disorders, published by Elsevier Science Ltd, is a leading journal that serves as a vital resource in the field of neurology, particularly focused on multiple sclerosis and its associated conditions. This esteemed journal, which holds a Q1 ranking in Medicine (miscellaneous) and Q2 ranking in both Neurology and Clinical Neurology, delivers high-impact research findings and clinical insights crucial for advancing the understanding and management of multiple sclerosis. With an ISSN of 2211-0348 and an E-ISSN of 2211-0356, it provides valuable content from 2012 to 2024 aimed at researchers, healthcare professionals, and students dedicated to improving patient outcomes and fostering innovative strategies in treatment. Additionally, the journal's presence in the Scopus rankings highlights its relevance and influence in the academic community, ranking 121 out of 400 in Clinical Neurology and 59 out of 192 in Neuroscience. This comprehensive platform encourages the dissemination of cutting-edge knowledge and clinical practices, making it an essential tool for those committed to the field of neurology and related research.

Journal of Behavioral and Cognitive Therapy, published by ELSEVIER, is an esteemed academic journal dedicated to advancing the fields of clinical psychology, neuropsychology, and psychiatry through rigorous research and innovative practices. With an ISSN of 2589-9791 and Q2 rankings in both Clinical Psychology and Neuropsychology as of 2023, it demonstrates a strong commitment to fostering high-quality, impactful scholarship. Holding a Scopus Rank of 129 among 311 in Clinical Psychology, this journal serves as a significant platform for researchers and practitioners to disseminate their findings and engage in vital discussions surrounding behavioral and cognitive therapies. The journal's scope encompasses an array of topics pertinent to mental health, providing valuable insights that empower professionals and students alike. Although not Open Access, articles published within this journal have the potential to reach a diverse audience across the globe, enhancing collaboration and knowledge exchange in the critical arena of mental health. Located in France, the Journal of Behavioral and Cognitive Therapy continues to contribute to the global discourse on evidence-based practices and therapeutic innovations.